Borinaga, Sou Chee G.

HRN: 28-99-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/14/2026
05/16/2026
IVT
500MG
Q8
S/P LTCS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: